v3.24.1.u1
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Revenue:    
Total revenue, net $ 51,936 $ 45,774
Operating expenses:    
Selling, general and administrative 68,914 61,920
Research and development 14,393 17,532
Amortization 545 545
Total operating expenses 98,763 92,484
Loss from continuing operations (46,827) (46,710)
Interest income 2,996 2,970
Interest expense (5,256) (4,497)
Other expense, net (438) (234)
Net loss from continuing operations (49,525) (48,471)
Net loss from discontinued operations (3,627) (11,322)
Total net loss (53,152) (59,793)
Unrealized gain (loss) (39) 249
Comprehensive loss $ (53,191) $ (59,544)
Basic and diluted net loss per share:    
Basic net loss Continuing operations (in dollars per share) $ (0.54) $ (0.60)
Diluted net loss Continuing operations (in dollars per share) (0.54) (0.60)
Basic net loss Discontinued operations (in dollars per share) (0.04) (0.14)
Diluted net loss Discontinued operations (in dollars per share) (0.04) (0.14)
Total net loss per basic (in dollars per share) (0.58) (0.74)
Total net loss per diluted (in dollars per share) $ (0.58) $ (0.74)
Basic weighted-average number of shares used in computing net loss per share (in shares) 91,919,018 81,134,111
Diluted weighted-average number of shares used in computing net loss per share (in shares) 91,919,018 81,134,111
Product revenue, net    
Revenue:    
Total revenue, net $ 51,719 $ 45,658
Operating expenses:    
Cost of product revenue (exclusive of amortization) 14,911 12,487
Collaboration revenue    
Revenue:    
Total revenue, net $ 217 $ 116